 |
 |
 |
 |
 |
Treatment Name: |
 |
Pilot trial of Innohep (Tinzaparin) Low Molecular Weight Heparin for primary prophylaxis of venous thromboembolism in brain tumor patients. |
 |
 |
 |
 |
Phase: |
 |
Other / Approved |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1261 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
60: Requires occasional assistance but is able to care for most of own needs |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
11/13/2005 |
 |
 |
 |
 |
Tumor Types: |
 |
Anaplastic Astrocytoma Any Malignant Brain Tumor Brainstem Glioma Craniopharyngioma Ependyoma Ganglioglioma Germ Cell Tumors Glioblastoma Multiforme Gliosarcoma Hemangioblastoma Low Grade Glioma Lymphomas Medulloblastoma Meningioma Metastatic Brain Tumor Mixed Glioma Oligodendroglioma High Grade Oligodendroglioma Low Grade Recurrent Malignant Pediatric Brain Tumors |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
See http://www.cancer.duke.edu/btc/ for details!
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Less-Toxics |
 |
 |
 |
 |
Contact: |
 |
Henry Friedman MD The Brain Tumor Center at Duke Rm 047 Baker House, Hospital South Trent Drive Durham, NC 27710- USA Phone: (919)684-5301 Fax: (919)684-6674 E-mail: fried003@mc.duke.edu Website: www.cancer.duke.edu/btc |
 |
 |